Bristol-Myers Squibb Company operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bristol-Myers Squibb Company with three other
companies in this sector in the United States:
sales of $22.47 billion
of which 100%
Teva Pharmaceutical Industries Limited
of which 55%
was Generic Medicines), and
Eli Lilly and Company
of which 44%
was Human pharmaceutical products - Endocrin).
During the year ended December of 2017, sales at
Bristol-Myers Squibb Company were $20.78 billion.
increase of 6.9%
versus 2016, when the company's sales were $19.43 billion.
This was the third consecutive year of growth at Bristol-Myers Squibb Company.